Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yingwei Li

Showing results (211-220 of 234) with videos related to

Pageof 24
Sort By:
Oncology Reports|February 28, 2014
miR-1236-3p represses the cell migration and invasion abilities by targeting ZEB1 in high-grade serous ovarian carcinomaYu Wang, Shi Yan, Xiaolin Liu, et al.
American Journal of Cancer Research|May 18, 2016
Overexpression and oncogenic function of HMGA2 in endometrial serous carcinogenesisLinxuan Wei, Xiaolin Liu, Wenjing Zhang, et al.
The New Phytologist|June 10, 2024
Domestication of rice may have changed its arbuscular mycorrhizal properties by modifying phosphorus nutrition-related traits and decreasing symbiotic compatibilityYingwei Li, Hanwen Chen, Ling Gu, et al.
Journal of the American Chemical Society|January 23, 2016
Transition Metal Nitride Coated with Atomic Layers of Pt as a Low-Cost, Highly Stable Electrocatalyst for the Oxygen Reduction ReactionXinlong Tian, Junming Luo, Haoxiong Nan, et al.
Cell Death & Disease|March 18, 2021
Splicing factor USP39 promotes ovarian cancer malignancy through maintaining efficient splicing of oncogenic HMGA2Shourong Wang, Zixiang Wang, Jieyin Li, et al.
Oncoimmunology|July 8, 2022
Oncolytic adenovirus with MUC16-BiTE shows enhanced antitumor immune response by reversing the tumor microenvironment in PDX model of ovarian cancerQiuman Wang, Xinyue Ma, Huan Wu, et al.
Frontiers in Pharmacology|October 19, 2018
Network Pharmacology-Based Validation of Caveolin-1 as a Key Mediator of Ai Du Qing Inhibition of Drug Resistance in Breast CancerNeng Wang, Bowen Yang, Xiaotong Zhang, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 17, 2015
MDC1 promotes ovarian cancer metastasis by inducing epithelial-mesenchymal transitionXiaolin Liu, Ruifen Dong, Zhijun Jiang, et al.
Journal of the American Chemical Society|April 12, 2023
A Double Open-Shelled Au<sub>43</sub> Nanocluster with Increased Catalytic Activity and StabilityYingwei Li, Hong Ki Kim, Ryan D McGillicuddy, et al.
Frontiers in Oncology|October 5, 2020
RECQL4, Negatively Regulated by miR-10a-5p, Facilitates Cell Proliferation and Invasion via MAFB in Ovarian CancerLi Guo, Yingwei Li, Chen Zhao, et al.
Pageof 24

Showing results (211-220 of 234) with videos related to

Sort By:
Pageof 24
Oncology Reports|February 28, 2014
miR-1236-3p represses the cell migration and invasion abilities by targeting ZEB1 in high-grade serous ovarian carcinomaYu Wang, Shi Yan, Xiaolin Liu, et al.
American Journal of Cancer Research|May 18, 2016
Overexpression and oncogenic function of HMGA2 in endometrial serous carcinogenesisLinxuan Wei, Xiaolin Liu, Wenjing Zhang, et al.
The New Phytologist|June 10, 2024
Domestication of rice may have changed its arbuscular mycorrhizal properties by modifying phosphorus nutrition-related traits and decreasing symbiotic compatibilityYingwei Li, Hanwen Chen, Ling Gu, et al.
Journal of the American Chemical Society|January 23, 2016
Transition Metal Nitride Coated with Atomic Layers of Pt as a Low-Cost, Highly Stable Electrocatalyst for the Oxygen Reduction ReactionXinlong Tian, Junming Luo, Haoxiong Nan, et al.
Cell Death & Disease|March 18, 2021
Splicing factor USP39 promotes ovarian cancer malignancy through maintaining efficient splicing of oncogenic HMGA2Shourong Wang, Zixiang Wang, Jieyin Li, et al.
Oncoimmunology|July 8, 2022
Oncolytic adenovirus with MUC16-BiTE shows enhanced antitumor immune response by reversing the tumor microenvironment in PDX model of ovarian cancerQiuman Wang, Xinyue Ma, Huan Wu, et al.
Frontiers in Pharmacology|October 19, 2018
Network Pharmacology-Based Validation of Caveolin-1 as a Key Mediator of Ai Du Qing Inhibition of Drug Resistance in Breast CancerNeng Wang, Bowen Yang, Xiaotong Zhang, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 17, 2015
MDC1 promotes ovarian cancer metastasis by inducing epithelial-mesenchymal transitionXiaolin Liu, Ruifen Dong, Zhijun Jiang, et al.
Journal of the American Chemical Society|April 12, 2023
A Double Open-Shelled Au<sub>43</sub> Nanocluster with Increased Catalytic Activity and StabilityYingwei Li, Hong Ki Kim, Ryan D McGillicuddy, et al.
Frontiers in Oncology|October 5, 2020
RECQL4, Negatively Regulated by miR-10a-5p, Facilitates Cell Proliferation and Invasion via MAFB in Ovarian CancerLi Guo, Yingwei Li, Chen Zhao, et al.
Pageof 24